Updated clinical data from VISTA101 presented at SITC 2024.Monotherapy arm fully enrolled and combination arm expected to be fully enrolled by ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

Elizabeth Mills of Willow Street and Shannon Zimmerman of Manheim Township have both undergone training and are certified ...

Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine ...

an anti-VISTA monoclonal antibody, as monotherapy and in combination with Merck’s anti-PD-1 therapy, KEYTRUDA, in patients with advanced solid tumors. KVA12123 cleared all six monotherapy dose levels ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

VISTA is another inhibitory checkpoint implicated in tumor ... “This study demonstrates the potential to expand the ...

Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine, designed to save lives by preventing disease recurrence in first-line ...

The service dog based in Sierra Vista, Arizona, recently retired after spending years ... who put his lovable personality and ...